AMALRIC Marianne
Onglets principaux
marianne.amalric@univ-amu.fr
Equipe(s) de recherche
Cognition et pathophysiologie des ganglions de la base
Publications in HAL
http://api.archives-ouvertes.fr/search/?&fq=authLastNameFirstName_s:%28%22Amalric+Marianne%22%29&fl=title_s,en_title_s,docid,label_s,en_label_s,docType_s,authIdHal_s,halId_s,structId_i,uri_s,keyword_s,en_keyword_s,authLastNameFirstName_s,journalTitle_s,abstract_s,en_abstract_s&sort=producedDate_tdate+desc
- Samira Ztaou, Juliette Lhost, Isabelle Watabe, Giulia Torromino, Marianne Amalric. Striatal cholinergic interneurons regulate cognitive and affective dysfunction in partially dopamine-depleted mice. European Journal of Neuroscience, Wiley, 2018, 48 (9), pp.2988-3004. ⟨10.1111/ejn.14153⟩. ⟨hal-01974268⟩
- Christiane Mourre, Christine Manrique, Jeremy Camon, Sabrine Aidi-Knani, Thierry Deltheil, et al.. Changes in SK channel expression in the basal ganglia after partial nigrostriatal dopamine lesions in rats: Functional consequences. Neuropharmacology, Elsevier, 2017, 113, pp.519 - 532. ⟨10.1016/j.neuropharm.2016.11.003⟩. ⟨hal-01401797⟩
- Marianne Amalric. Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease. Current Opinion in Pharmacology, Elsevier, 2015, 20, pp.29-34. ⟨10.1016/j.coph.2014.11.001⟩. ⟨hal-01384021⟩
- Sabrine Aidi-Knani, Imed Regaya, Marianne Amalric, Christiane Mourre. Kv4 channel blockade reduces motor and neuropsychiatric symptoms in rodent models of Parkinson's disease. Behavioural Pharmacology, Lippincott, Williams & Wilkins, 2015, 26 (1-2, SI), pp.91-100. ⟨10.1097/FBP.0000000000000107⟩. ⟨hal-01384019⟩
- Nicolas Maurice, Thierry Deltheil, Christophe Melon, Bertrand Degos, Christiane Mourre, et al.. Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson's Disease. PLoS ONE, Public Library of Science, 2015, 10 (11), pp.e0142838. ⟨10.1371/journal.pone.0142838⟩. ⟨hal-01384032⟩
- Nicolas Maurice, Martine Liberge, Florence Jaouen, Samira Ztaou, Marwa Hanini, et al.. Striatal Cholinergic Interneurons Control Motor Behavior and Basal Ganglia Function in Experimental Parkinsonism. Cell Reports, Elsevier (Cell Press), 2015, 13 (4), pp.657-666. ⟨10.1016/j.celrep.2015.09.034⟩. ⟨hal-01384026⟩
- Thierry Deltheil, Nathalie Turle-Lorenzo, Marianne Amalric. Effects of Group III mGluR Modulation in the Globus Pallidus of Parkinsonian Rats. Current Neuropharmacology, Bentham Science Publishers, 2014, 12 (1), pp.13-14. ⟨hal-01384058⟩
- Lin Chen, Thierry Deltheil, Nathalie Turle-Lorenzo, Martine Liberge, Corinne Rosier, et al.. SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats. International Journal of Neuropsychopharmacology, Oxford University Press (OUP), 2014, 17 (8), pp.1295-1306. ⟨10.1017/S1461145714000236⟩. ⟨hal-01384068⟩
- Francesca Manago, Sébastien Lopez, Alberto Oliverio, Marianne Amalric, Andrea Mele, et al.. Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice. Psychopharmacology, Springer Verlag, 2013, 226 (3), pp.541-550. ⟨10.1007/s00213-012-2925-4⟩. ⟨hal-01384085⟩
- Cyril Goudet, Bruno Vilar, Tiphanie Courtiol, Thierry Deltheil, Thomas Bessiron, et al.. A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential.. FASEB Journal, Federation of American Society of Experimental Biology, 2012, 26 (4), pp.1682-93. ⟨10.1096/fj.11-195941⟩. ⟨hal-01182946⟩
- Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, et al.. The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with L-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease. Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, 2012, 340 (2), pp.404-421. ⟨10.1124/jpet.111.187443⟩. ⟨hal-01384126⟩
- Cyril Goudet, Bruno Vilar, Tiphanie Courtiol, Thierry Deltheil, Thomas Bessiron, et al.. A new Selective Metabotropic Glutamate Receptor type 4 Agonist Reveals New ways to Develop Subtype Selective Orthosteric Ligands with Potential Therapeutic Effects. Current Neuropharmacology, Bentham Science Publishers, 2011, 9 (1), pp.26. ⟨hal-01384798⟩
- Thierry Deltheil, Nathalie Turle-Lorenzo, Marianne Amalric. Orthosteric Group III mGlu Receptor Agonists for Parkinson's Disease Treatment: Symptomatic and Neurochemical Action on Pallidal Synaptic Transmission. Current Neuropharmacology, Bentham Science Publishers, 2011, 9 (1), pp.14-15. ⟨hal-01384803⟩
- Roula Moussa, Bruno Poucet, Marianne Amalric, Francesca Sargolini. Contributions of dorsal striatal subregions to spatial alternation behavior. Learning and Memory, Cold Spring Harbor Laboratory Press, 2011, 18 (7), pp.444-451. ⟨10.1101/lm.2123811⟩. ⟨hal-01384807⟩
- Isabelle A. Lemasson, Chelliah Selvam, Nadia Oueslati, Isabelle Brabet, Tiphanie Courtiol, et al.. Is metabotropic glutamate receptor mGlu4R a good target to treat Parkinson's disease symptoms? Design and evaluation of potent and selective agonists. Abstracts of Papers of the American Chemical Society, American Chemical Society, 2009, 238. ⟨hal-01384832⟩
- Elvira de Leonibus, Francesca Manago, Francesco Giordani, Francesco Petrosino, Sébastien Lopez, et al.. Metabotropic Glutamate Receptors 5 Blockade Reverses Spatial Memory Deficits in a Mouse Model of Parkinson's Disease. Neuropsychopharmacology, Nature Publishing Group, 2009, 34 (3), pp.729-738. ⟨10.1038/npp.2008.129⟩. ⟨hal-01384831⟩
- Pauline Sibille, Sébastien Lopez, Isabelle Brabet, Ornella Valenti, Nadia Oueslati, et al.. Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists.. Journal of Medicinal Chemistry, American Chemical Society, 2007, 50 (15), pp.3585-95. ⟨10.1021/jm070262c⟩. ⟨inserm-00318976⟩
- Sebastien Lopez, Nathalie Turle-Lorenzo, Francine Acher, Elvira de Leonibus, Andrea Mele, et al.. Targeting Group III Metabotropic Glutamate Receptors Produces Complex Behavioral Effects in Rodent Models of Parkinson's Disease. Journal of Neuroscience, Society for Neuroscience, 2007, 27(25):, ⟨10.1523/JNEUROSCI.0299-07.2007⟩. ⟨hal-00165896⟩
- Elvira de Leonibus, Tiziana Pascucci, Sébastien Lopez, Alberto Oliverio, Marianne Amalric, et al.. Spatial deficits in a mouse model of Parkinson disease. Psychopharmacology, Springer Verlag, 2007, 194 (4), pp.517-525. ⟨10.1007/s00213-007-0862-4⟩. ⟨hal-01384868⟩
- Nathalie Turle-Lorenzo, Beatrice Maurin, Carole Puma, Claire Chezaubernard, Philippe Morain, et al.. The dopamine agonist Piribedil with L-DOPA improves attentional dysfunction: Relevance for Parkinson's disease. Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, 2006, 319 (2), pp.914-923. ⟨10.1124/jpet.106.109207⟩. ⟨hal-01384880⟩
